Léim chuig an ábhar
VuFind
English
Deutsch
Español
Français
Italiano
日本語
Nederlands
Português
Português (Brasil)
中文(简体)
中文(繁體)
Türkçe
עברית
Gaeilge
Cymraeg
Ελληνικά
Català
Euskara
Русский
Čeština
Suomi
Svenska
polski
Dansk
slovenščina
اللغة العربية
বাংলা
Galego
Tiếng Việt
Hrvatski
हिंदी
Հայերէն
Українська
Sámegiella
Монгол
Teanga
Gach réimse
Teideal
Údar
Ábhar
Gairmuimhir
ISBN/ISSN
Clib
AIMSIGH
CASTA
The interferon beta-1b 16-year...
Luaigh é seo
Seol mar théacs é seo
Seol é seo mar r-phost
Priontáil
Easpórtáil taifead
Easpórtáil chuig RefWorks
Easpórtáil chuig EndNoteWeb
Easpórtáil chuig EndNote
Buan-nasc
The interferon beta-1b 16-year long-term follow-up study: Neutralizing antibodies and clinical outcomes
Sonraí bibleagrafaíochta
Príomhchruthaitheoirí:
Reder, A
,
Ebers, G
,
Goodin, D
,
Li, D
,
Traboulsee, A
,
Beckman, K
,
Konieczny, A
Formáid:
Conference item
Foilsithe / Cruthaithe:
2008
Stoc
Cur síos
Míreanna comhchosúla
Amharc foirne
Míreanna comhchosúla
The final results of the interferon beta-1b 16-year long-term follow-up study
de réir: Ebers, G, et al.
Foilsithe / Cruthaithe: (2006)
Long-term follow-up of the original interferon-beta1b trial in multiple sclerosis: design and lessons from a 16-year observational study.
de réir: Ebers, G, et al.
Foilsithe / Cruthaithe: (2009)
Cross-sectional study assessing long-term safety of interferon-beta-1b for relapsing-remitting MS.
de réir: Reder, A, et al.
Foilsithe / Cruthaithe: (2010)
Relationship between early clinical characteristics and long term disability outcomes: 16 year cohort study (follow-up) of the pivotal interferon β-1b trial in multiple sclerosis
de réir: Goodin, D, et al.
Foilsithe / Cruthaithe: (2012)
Relationship between early clinical characteristics and long term disability outcomes: 16 year cohort study (follow-up) of the pivotal interferon β-1b trial in multiple sclerosis.
de réir: Goodin, D, et al.
Foilsithe / Cruthaithe: (2012)